Literature DB >> 1652135

Characterization and comparison of avian and murine helper cell lines for production of replication-defective retroviruses for avian transformation.

M K Highkin1, G G Krivi, P J Hippenmeyer.   

Abstract

Several approaches were taken to identify improved helper cell lines for the production of replication-defective avian retroviral vectors for avian transformation. Both QT6 and D17 cells were engineered to become helper cell lines for the production of reticuloendotheliosis virus vectors. The results showed that the majority of lines from the D17, QT6, and D17C3 cells produced titers in the 10(2) to 10(3) cfu/mL range, with one QT6 line producing 10(5) cfu/mL. This high producer line was relatively free of helper virus when restricted to low passage. An amphotropic murine cell line produced a 6- to 10-fold higher amount of virus and had a comparable higher titer on chicken cells, suggesting possible application to avian transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652135     DOI: 10.3382/ps.0700970

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  3 in total

1.  A novel transcriptional enhancer is involved in the prolactin- and extracellular matrix-dependent regulation of beta-casein gene expression.

Authors:  C Schmidhauser; G F Casperson; C A Myers; K T Sanzo; S Bolten; M J Bissell
Journal:  Mol Biol Cell       Date:  1992-06       Impact factor: 4.138

2.  Protease-deficient herpes simplex virus protects mice from lethal herpesvirus infection.

Authors:  P J Hippenmeyer; A M Rankin; V A Luckow; G R Neises
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3.

Authors:  J W Thomas; C M Baum; W F Hood; B Klein; J B Monahan; K Paik; N Staten; M Abrams; J P McKearn
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.